Detalhe da pesquisa
1.
First-line regorafenib with nivolumab and chemotherapy in advanced oesophageal, gastric, or gastro-oesophageal junction cancer in the USA: a single-arm, single-centre, phase 2 trial.
Lancet Oncol
; 24(10): 1073-1082, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37666264
2.
Durvalumab and PET-Directed Chemoradiation in Locally Advanced Esophageal Adenocarcinoma: A Phase Ib/II Study.
Ann Surg
; 278(3): e511-e518, 2023 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36762546
3.
Early infection is an independent risk factor for increased mortality in patients with culture-confirmed infected pancreatic necrosis.
Pancreatology
; 22(1): 67-73, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34774414
4.
Should chemoradiotherapy be standard to maximise cure in localised gastro-oesophageal cancer?
Lancet Oncol
; 23(7): 847-849, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35772454
5.
Top advances in esophageal/gastroesophageal junction cancers in 2021.
Cancer
; 128(10): 1894-1899, 2022 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35179774
6.
Clinical utility of plasma cell-free DNA in pancreatic neuroendocrine neoplasms.
Endocr Relat Cancer
; 31(4)2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38252063
7.
The Prognostic Nutritional Index in patients with microsatellite instability-high metastatic gastric or gastroesophageal cancers receiving immune checkpoint inhibitors.
Dig Liver Dis
; 2024 May 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38772790
8.
Precision medicine for pancreatic cancer: Characterizing the clinico-genomic landscape and outcomes of KRAS G12C-mutated disease.
J Natl Cancer Inst
; 2024 May 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38702822
9.
A Novel Approach to Quantify Heterogeneity of Intrahepatic Cholangiocarcinoma: the Hidden-Genome Classifier.
Clin Cancer Res
; 2024 Jun 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38864854
10.
Clinical Utility of 18F-2-Fluoro-deoxy-d-glucose PET Imaging in Locally Advanced Esophageal/Gastroesophageal Junction Adenocarcinoma.
Diagnostics (Basel)
; 13(11)2023 May 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-37296735
11.
Impact of Helicobacter pylori infection status on outcomes among patients with advanced gastric cancer treated with immune checkpoint inhibitors.
J Immunother Cancer
; 11(10)2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37899129
12.
Outcomes and a prognostic classifier in patients with microsatellite instability-high metastatic gastric cancer receiving PD-1 blockade.
J Immunother Cancer
; 11(6)2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37277193
13.
Targeted Molecular Profiling of Circulating Cell-Free DNA in Patients With Advanced Hepatocellular Carcinoma.
JCO Precis Oncol
; 7: e2300272, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37769223
14.
Advanced Bile Duct Cancers: A Focused Review on Current and Emerging Systemic Treatments.
Cancers (Basel)
; 14(7)2022 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35406572
15.
Targeting KRAS in Pancreatic Cancer.
J Pers Med
; 12(11)2022 Nov 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36579598
16.
COVID-19-related mortality in cancer patients in an Irish setting.
Ir J Med Sci
; 191(5): 2013-2018, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34697787
17.
Delivery of systemic anti-cancer therapy during the COVID-19 pandemic.
Ir J Med Sci
; 191(2): 559-562, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33977394
18.
Outcomes and Molecular Features of Brain Metastasis in Gastroesophageal Adenocarcinoma.
JAMA Netw Open
; 5(8): e2228083, 2022 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36001319
19.
ATM Germline-Mutated Gastroesophageal Junction Adenocarcinomas: Clinical Descriptors, Molecular Characteristics, and Potential Therapeutic Implications.
J Natl Cancer Inst
; 114(5): 761-770, 2022 05 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35078243
20.
Emerging RAS-directed therapies for cancer.
Cancer Drug Resist
; 4(3): 543-558, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-35582302